搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱(chēng) 貨號(hào) 規(guī)格
Recombinant Listeria monocytogenes serotype 4a MutS2 protein (mutS2), partial CSB-YP491688LPW
CSB-EP491688LPW
CSB-BP491688LPW
CSB-MP491688LPW
CSB-EP491688LPW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Desulfovibrio vulgaris Phosphoribosylglycinamide formyltransferase 2 (purT) CSB-YP491689DJR
CSB-EP491689DJR
CSB-BP491689DJR
CSB-MP491689DJR
CSB-EP491689DJR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Desulfovibrio vulgaris Protein-L-isoaspartate O-methyltransferase (pcm) CSB-YP491690DJR
CSB-EP491690DJR
CSB-BP491690DJR
CSB-MP491690DJR
CSB-EP491690DJR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Desulfovibrio vulgaris Protein CrcB homolog (crcB), partial CSB-YP491691DJR1
CSB-EP491691DJR1
CSB-BP491691DJR1
CSB-MP491691DJR1
CSB-EP491691DJR1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Desulfovibrio vulgaris Heat-inducible transcription repressor HrcA (hrcA) CSB-YP491692DJR
CSB-EP491692DJR
CSB-BP491692DJR
CSB-MP491692DJR
CSB-EP491692DJR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Desulfovibrio vulgaris 4-hydroxy-3-methylbut-2-enyl diphosphate reductase (ispH) CSB-YP491693DJR
CSB-EP491693DJR
CSB-BP491693DJR
CSB-MP491693DJR
CSB-EP491693DJR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Desulfovibrio vulgaris Ribosome maturation factor RimP (rimP) CSB-YP491694DJR
CSB-EP491694DJR
CSB-BP491694DJR
CSB-MP491694DJR
CSB-EP491694DJR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Desulfovibrio vulgaris 30S ribosomal protein S12 (rpsL) CSB-YP491695DJR
CSB-EP491695DJR
CSB-BP491695DJR
CSB-MP491695DJR
CSB-EP491695DJR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Desulfovibrio vulgaris 30S ribosomal protein S19 (rpsS) CSB-YP491696DJR
CSB-EP491696DJR
CSB-BP491696DJR
CSB-MP491696DJR
CSB-EP491696DJR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Desulfovibrio vulgaris 50S ribosomal protein L14 (rplN) CSB-YP491697DJR
CSB-EP491697DJR
CSB-BP491697DJR
CSB-MP491697DJR
CSB-EP491697DJR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Desulfovibrio vulgaris 50S ribosomal protein L18 (rplR) CSB-YP491698DJR
CSB-EP491698DJR
CSB-BP491698DJR
CSB-MP491698DJR
CSB-EP491698DJR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Desulfovibrio vulgaris 50S ribosomal protein L36 (rpmJ) CSB-YP491699DJR
CSB-EP491699DJR
CSB-BP491699DJR
CSB-MP491699DJR
CSB-EP491699DJR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Desulfovibrio vulgaris Phosphoribosylformylglycinamidine cyclo-ligase (purM) CSB-YP491700DJR
CSB-EP491700DJR
CSB-BP491700DJR
CSB-MP491700DJR
CSB-EP491700DJR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Desulfovibrio vulgaris Protein MraZ (mraZ) CSB-YP491701DJR
CSB-EP491701DJR
CSB-BP491701DJR
CSB-MP491701DJR
CSB-EP491701DJR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Desulfovibrio vulgaris Glycine--tRNA ligase beta subunit (glyS), partial CSB-YP491702DJR
CSB-EP491702DJR
CSB-BP491702DJR
CSB-MP491702DJR
CSB-EP491702DJR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Desulfovibrio vulgaris Phenylalanine--tRNA ligase alpha subunit (pheS) CSB-YP491703DJR
CSB-EP491703DJR
CSB-BP491703DJR
CSB-MP491703DJR
CSB-EP491703DJR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Desulfovibrio vulgaris DNA-directed RNA polymerase subunit omega (rpoZ) CSB-YP491704DJR
CSB-EP491704DJR
CSB-BP491704DJR
CSB-MP491704DJR
CSB-EP491704DJR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Desulfovibrio vulgaris Protein translocase subunit SecA (secA), partial CSB-YP491705DJR
CSB-EP491705DJR
CSB-BP491705DJR
CSB-MP491705DJR
CSB-EP491705DJR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Desulfovibrio vulgaris 30S ribosomal protein S18 (rpsR) CSB-YP491706DJR
CSB-EP491706DJR
CSB-BP491706DJR
CSB-MP491706DJR
CSB-EP491706DJR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Desulfovibrio vulgaris 50S ribosomal protein L21 (rplU) CSB-YP491707DJR
CSB-EP491707DJR
CSB-BP491707DJR
CSB-MP491707DJR
CSB-EP491707DJR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶(hù)提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€(xiàn)留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>